Payne H - Search Results

1

An algorithm for managing the failure of external beam radiotherapy in prostate cancer.

Dudderidge T, Payne H, Emberton M. Dudderidge T, et al. Among authors: payne h. BJU Int. 2007 Sep;100(3):518-27. doi: 10.1111/j.1464-410X.2007.06999.x. Epub 2007 Jun 15. BJU Int. 2007. PMID: 17573894 Review.

2

Penile preservation in squamous cell carcinoma of the bulbomembranous urethra.

Christopher N, Arya M, Brown RS, Payne HA, Woodhouse CR, Ralph DJ. Christopher N, et al. Among authors: payne ha. BJU Int. 2002 Mar;89(4):464-5. doi: 10.1046/j.1464-4096.2001.00135.x. BJU Int. 2002. PMID: 11872045 No abstract available.

3

Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study.

Nathan TR, Whitelaw DE, Chang SC, Lees WR, Ripley PM, Payne H, Jones L, Parkinson MC, Emberton M, Gillams AR, Mundy AR, Bown SG. Nathan TR, et al. Among authors: payne h. J Urol. 2002 Oct;168(4 Pt 1):1427-32. doi: 10.1016/S0022-5347(05)64466-7. J Urol. 2002. PMID: 12352410 Clinical Trial.

4

Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

Birtle AJ, Freeman A, Payne HA, Masters JR, Harland SJ. Birtle AJ, et al. Among authors: payne ha. BJU Int. 2003 Sep;92(4):490. doi: 10.1046/j.1464-410x.2003.t01-1-04376.x. BJU Int. 2003. PMID: 12930449 No abstract available.

5

Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment.

Sculpher M, Bryan S, Fry P, de Winter P, Payne H, Emberton M. Sculpher M, et al. Among authors: payne h. BMJ. 2004 Feb 14;328(7436):382. doi: 10.1136/bmj.37972.497234.44. Epub 2004 Jan 29. BMJ. 2004. PMID: 14751919 Free PMC article. Clinical Trial.

6

Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of <10 ng/mL.

Birtle AJ, Freeman A, Masters JR, Payne HA, Harland SJ; BAUS Section of Oncology Cancer Registry. Birtle AJ, et al. BJU Int. 2005 Aug;96(3):303-7. doi: 10.1111/j.1464-410X.2005.05619.x. BJU Int. 2005. PMID: 16042718

7

What are the risks of second cancer formation after radiotherapy to the prostate?

Goldstraw MA, Payne H, Kirby RS. Goldstraw MA, et al. Among authors: payne h. BJU Int. 2006 Sep;98(3):489-91. doi: 10.1111/j.1464-410X.2006.06288.x. BJU Int. 2006. PMID: 16925740 No abstract available.

8

Transdermal oestrogen therapy as a second-line hormonal intervention in prostate cancer: a bad experience.

Kandola S, Anyamene N, Payne H, Harland S. Kandola S, et al. Among authors: payne h. BJU Int. 2007 Jan;99(1):53-5. doi: 10.1111/j.1464-410X.2007.06543.x. BJU Int. 2007. PMID: 17227492

9

Differences and commonalities in the management of locally advanced prostate cancer: results from a survey of oncologists and urologists in the UK.

Payne HA, Gillatt DA. Payne HA, et al. BJU Int. 2007 Mar;99(3):545-53. doi: 10.1111/j.1464-410X.2006.06651.x. BJU Int. 2007. PMID: 17407513

10

Radiotherapy and androgen deprivation in combination after local surgery (RADICALS): a new Medical Research Council/National Cancer Institute of Canada phase III trial of adjuvant treatment after radical prostatectomy.

Parker C, Sydes MR, Catton C, Kynaston H, Logue J, Murphy C, Morgan RC, Mellon K, Morash C, Parulekar W, Parmar MK, Payne H, Savage C, Stansfeld J, Clarke NW; (RADICALS Trial Management Group). Parker C, et al. Among authors: payne h. BJU Int. 2007 Jun;99(6):1376-9. doi: 10.1111/j.1464-410X.2007.06844.x. Epub 2007 Apr 8. BJU Int. 2007. PMID: 17428247 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

413 results

Search Page